Abstract
The aim of the present study was to analyze heart function in subclinical hyperthyroidism (sHT) in otherwise healthy subjects by new methods using intramyocardial ultrasonic techniques. Twenty-four newly diagnosed and untreated sHT patients (20 women, 4 men; mean age: 42±4 yr) and 24 sex- and age-matched healthy volunteers were studied. All subjects were submitted to conventional 2D color-Doppler echocardiography, pulsed wave tissue Doppler imaging (PWTDI) for the analysis of diastolic function, color Doppler myocardial imaging (CDMI) for the analysis of regional strain and strain rate (SR) expression of regional myocardial deformability, and to integrated backscatter (IBS) for the evaluation of intrinsic contractility and tissue characterization. Regional myocardial systolic strain findings were significantly higher in sHT patients when compared with controls (p<0.001). Considering diastolic SR, the early phase of diastolic SR was compromised in sHT subjects as compared with controls (p<0.001). Cyclic variation index (CVI), expression of intrinsic contractility, was significantly higher in sHT subjects in comparison with controls (p<0.0001). IBS values were comparable between the 2 study groups. In conclusion, the present study suggests that in patients with sHT early systolic hyperdeformability and hypercontractility are present, together with impairment of both active and passive phases of diastole. On the contrary, no left ventricular hypertrophy or other structural alterations are documented.
Similar content being viewed by others
References
Ladenson PW. Thyrotoxicosis and the heart: something old and something new. J Clin Endocrinol Metab 1993, 77: 332–3.
Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev 2005, 26: 704–28.
Sgarbi JA, Villaça F, Garbeline B, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities. J Clin Endocrinol Metab 2003, 88: 1672–7.
Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 2002, 87: 968–74.
Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004, 59: 31–50.
Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000, 85: 4701–5.
Shapiro LE, Sievert R, Ong L, et al. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab 1997, 82: 2592–5.
McDermott MT, Woodmansee WW, Haugen BR, Smart A, Ridgway EC. The management of subdinical hyperthyroidism by thyroid specialists. Thyroid 2003, 13: 1133–9.
Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on heart. Ann Intern Med 2002, 137: 904–14.
Mercuro G, Panzuto MG, Bina A, et al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 2000, 85: 159–64.
Holland MR, Wallace KD, Miller JG. Potential relationships among myocardial stiffness, the measured level of myocardial backscatter (“image brightness”) and the magnitude of the systematic variation of backscatter (cyclic variation) over the heart cycle. J Am Soc Echocardiogr 2004, 17: 1131–7.
Edvardsen T, Gerber BL, Garot J, Bluemke DA, Lima JAO, Smiseth OA. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation 2002, 106: 50–6.
Sutherland GR, Di Salvo G, Claus P, D’hooge J, Bijnens B. Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. J Am Soc Echocardiogr 2004, 17: 788–802.
Di Bello V, Giorgi D, Talini E, et al. Incremental value of ultrasonic tissue characterization (backscatter) in evaluation of left ventricular myocardial structure and mechanics in essential arterial hypertension. Circulation 2003, 107: 74–80.
Di Bello V, Giorgi D, Viacava P, et al. Severe aortic stenosis and myocardial function: diagnostic and prognostic usefulness of ultrasonic integrated backscatter analysis. Circulation 2004, 110: 849–55.
Bogazzi F, Di Bello V, Palagi C, et al. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study. Clin Endocrinol (Oxf) 2005, 62: 590–6.
Di Bello V, Santini F, Di Cori A, et al. Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a color Doppler imaging study. Int J Obes (Lond) 2006, 30: 948–56.
Giorgi D, Di Bello V, Pedrinelli R, et al. Ultrasonic tissue characterization and Doppler tissue imaging in the analysis of the left ventricularfunction in essential arterial hypertension: a preliminary study. Echocardiography 2002, 19: 187–98.
Oki T, Tabata T, Yamada H, et al. Left ventricular diastolic properties of hypertensive patients measured by pulsed tissue Doppler imaging. J Am Soc Echocardiogr 1998, 11: 1106–12.
Di Bello V, Giorgi D, Pedrinelli R, et al. Left ventricular hypertrophy and its regression in essential arterial hypertension: a tissue Doppler imaging study. Am J Hypert 2004, 17: 882–90.
Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial Strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function. Circulation 2000, 102: 1158–64.
D’hooge J, Heimdal A, Jamal F, et al. Regional strain and SR measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 2000, 1: 154–70.
Bland JM, Altman DG. Measurement error and correlations coefficients. BMJ 1996, 313: 41–2.
Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228–38.
Ross DS. Subclinical thyrotoxicosis. In: Braverman LE and Utiger RD, eds. Werner and Ingbar’s The Thyroid: a fundamental and Clinical text. 8th ed. Philadelphia: Lippincott Williams and Wilkins 2000, 1016–20.
Papi G, Pearce EN, Braverman LE, Betterle C, Roti E. A clinical and therapeutic approach to thyrotoxicosis with thyroidstimulating hormone suppression. Am J Med 2005, 118: 349–61.
Tseng KH, Walfish PG, Persaud JA, Gilbert BW. Concurrent aortic and mitral valve echocardiography permits measurements of systolic time intervals as an index of peripheral tissue thyroid functional status. J Clin Endocrinol Metab 1989, 69: 633–8.
Dörr M, Wolff B, Robinson DM, et al. The Association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab 2005, 90: 673–7.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001, 344: 501–9.
Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard M, Gammage MD. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 1996, 75: 363–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Research project for the technologic innovation in the diagnosis and prognosis of cardiovascular diseases. (Dir. Prof. M. Mariani).
Rights and permissions
About this article
Cite this article
Di Bello, V., Aghini-Lombardi, F., Monzani, F. et al. Early abnormalities of left ventricular myocardial characteristics associated with subclinical hyperthyroidism. J Endocrinol Invest 30, 564–571 (2007). https://doi.org/10.1007/BF03346350
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346350